XML 24 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Segment Information - Summary of Net Margin by SBU Reporting Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Segment Reporting Information [Line Items]        
Total net margin $ 36,098 $ 33,558 $ 62,236 $ 65,628
General and administrative 22,506 18,214 44,075 36,074
Research and development 6,451 6,313 12,296 12,246
Restatements and related costs 2,213 2,327 8,129 10,633
Operating income (loss) 4,928 6,704 (2,264) 6,675
Operating Segments [Member] | BioStim [Member]        
Segment Reporting Information [Line Items]        
Total net margin 16,787 17,706 30,800 32,726
Operating Segments [Member] | Biologics [Member]        
Segment Reporting Information [Line Items]        
Total net margin 7,285 6,496 13,229 12,997
Operating Segments [Member] | Extremity Fixation [Member]        
Segment Reporting Information [Line Items]        
Total net margin 9,149 6,656 16,165 13,590
Operating Segments [Member] | Spine Fixation [Member]        
Segment Reporting Information [Line Items]        
Total net margin 3,173 3,130 2,644 7,189
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Total net margin (296) (430) (602) (874)
Material Reconciling Items [Member]        
Segment Reporting Information [Line Items]        
General and administrative 22,506 18,214 44,075 36,074
Research and development 6,451 6,313 12,296 12,246
Restatements and related costs $ 2,213 $ 2,327 $ 8,129 $ 10,633